The primary goal of this multi-faceted educational program is to improve the PCP’s ability to recognize the signs and symptoms of psoriatic disease, when to refer to specialty, and how to collaboratively advance patients along the correct treatment pathway in order to improve patient health outcomes.
In this Clinical Coffee Break, Dr. Jacob Levitt reviews the different presentations of plaque psoriasis and compares the various therapy classes, including topical corticosteroids, conventional systemic therapies, and biologics. He also discusses how to select treatments based on symptom severity, and which treatments to avoid in special populations, such as pregnant women and those with renal insufficiency.
The talk will cover inflammatory, neoplastic, and infectious diseases of the face, including periorbital, perioral, and malar geographies. Participants will learn to identify lesions in the context of differential diagnosis and receive an overview of first-line therapeutic approaches. Where applicable, newly approved medications in dermatology will be reviewed (e.g., psoriasis, eczema, and rosacea). Some disease states to be covered include acne, rosacea, allergic contact dermatitis, dermatomyositis, melanoma, basal cell carcinoma, melasma, and sarcoidosis.
There have been many advances in the medical management of dermatologic disease. Office Dermatology will cover the diagnosis and management of common skin disorders and provide an update on therapeutics.